These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3344743)

  • 1. The long-term outcome of hepatitis B infection in hemodialysis patients.
    Harnett JD; Parfrey PS; Kennedy M; Zeldis JB; Steinman TI; Guttmann RD
    Am J Kidney Dis; 1988 Mar; 11(3):210-3. PubMed ID: 3344743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
    Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
    Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
    Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
    Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality.
    Josselson J; Kyser BA; Weir MR; Sadler JH
    Am J Kidney Dis; 1987 Jun; 9(6):456-61. PubMed ID: 3591792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
    Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
    J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients.
    Parfrey PS; Forbes RD; Hutchinson TA; Beaudoin JG; Dauphinee WD; Hollomby DJ; Guttmann RD
    Transplantation; 1984 May; 37(5):461-6. PubMed ID: 6375001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy.
    Chung SJ; Kim JK; Park MC; Park YB; Lee SK
    J Rheumatol; 2009 Nov; 36(11):2416-20. PubMed ID: 19797507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection in patients with chronic liver disease and healthy controls in north-Sulawesi, Indonesia.
    Wolff AP; Ruys AH; Dolmans WM; Van Loon AM; Pangalila PF
    Trop Geogr Med; 1990 Jul; 42(3):221-5. PubMed ID: 2293430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of renal transplantation on the course of hepatitis B liver disease.
    Parfrey PS; Forbes RD; Hutchinson TA; Kenick S; Farge D; Dauphinee WD; Seely JF; Guttmann RD
    Transplantation; 1985 Jun; 39(6):610-5. PubMed ID: 3890290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed HBsAg clearance in chronic hepatitis B viral infection.
    Lindsay KL; Redeker AG; Ashcavai M
    Hepatology; 1981; 1(6):586-9. PubMed ID: 7308992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria.
    Naoumov NV; Gueorgiev A; Ognyanov M; Maleev A
    Hepatogastroenterology; 1986 Apr; 33(2):49-51. PubMed ID: 3721387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids.
    Sandrini S; Callea F; Cristinelli L; Savoldi S; Setti G; Scaini P; Scolari F; Scalzini A; Pizzoccolo G; Maiorca R
    Nephrol Dial Transplant; 1990; 5(7):525-30. PubMed ID: 2130300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of chronic hepatitis B in heart transplant recipients.
    Wedemeyer H; Pethig K; Wagner D; Flemming P; Oppelt P; Petzold DR; Haverich A; Manns MP; Boeker KH
    Transplantation; 1998 Nov; 66(10):1347-53. PubMed ID: 9846521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B surface antigenemia at birth: a long-term follow-up study.
    Tang JR; Hsu HY; Lin HH; Ni YH; Chang MH
    J Pediatr; 1998 Sep; 133(3):374-7. PubMed ID: 9738719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine.
    Park SK; Yang WS; Lee YS; Jung HH; Chang JW; Choi HJ; Han DJ; Park JS
    Nephrol Dial Transplant; 2001 Nov; 16(11):2222-8. PubMed ID: 11682671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory treatment of HBsAg positive chronic hepatitis with specific substance Maruyama (SSM).
    Okumura H; Satomura K; Aramaki T; Katsuta Y; Terada H; Sekiyama T; Akaike M; Otake M; Fujita K; Maruyama C
    Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):192-9. PubMed ID: 6736212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.